logo BDSP

Base documentaire


  1. Anti-rheumatic drug-prescribing behaviour of Australasian Rheumatologists 1984-1994.

    Article - En anglais

    The prescribing behaviour of Australian and New Zealand rheumatologists was studied in 1994 using a questionnaire. and the results compared with a similar questionnaire administered in 1984.

    Perceived differences in efficacy and toxicity for disease-modifying anti-rheumatic drugs (DMARDs) and cytotoxics were reported.

    Over the decade, methotrexate and sulphasalazine have become the most commonly used anti-rheumatic agents, and methotrexate is clearly seen as the most effective drug.

    Wide variations in monitoring practices for DMARDs were reported, highlighting the need for cost-effectiveness studies on monitoring.

    There was low usage of functional outcome measurements in assessing patients.

    Mots-clés Pascal : Polyarthrite rhumatoïde, Traitement, Chimiothérapie, Antirhumatismal, Immunodépresseur, Pratique professionnelle, Epidémiologie, Australie, Océanie, Prescription, Médecin, Efficacité traitement, Toxicité, Pronostic, Chronique, Système ostéoarticulaire pathologie, Rhumatisme inflammatoire, Immunopathologie, Maladie autoimmune

    Mots-clés Pascal anglais : Rheumatoid arthritis, Treatment, Chemotherapy, Antirheumatic agent, Immunosuppressive agent, Professional practice, Epidemiology, Australia, Oceania, Prescription, Physician, Treatment efficiency, Toxicity, Prognosis, Chronic, Diseases of the osteoarticular system, Inflammatory joint disease, Immunopathology, Autoimmune disease

    Logo du centre Notice produite par :
    Inist-CNRS - Institut de l'Information Scientifique et Technique

    Cote : 97-0320095

    Code Inist : 002B02L. Création : 12/09/1997.